首页> 外文期刊>Nature >GcMAF: our next-generation immunotherapy
【24h】

GcMAF: our next-generation immunotherapy

机译:GcMAF:我们的下一代免疫疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Saisei Mirai, based in Osaka, Japan, is a medical organization specializing in cancer immunotherapy. The name Saisei Mirai is derived from the Japanese words for regeneration and future. It is our mission to provide cancer patients with the latest, most effective treatments while also ensuring the best possible quality of life. Cancer immunotherapy is the use of the immune system to reject cancer. In particular, it involves stimulating the patient's immune system to locate and eliminate the cells that are cancerous. This is achieved with immune cells such as Natural Killer cells (NK cells), T Lymphocytes, Dendritic Cells (DC), and macrophages, among others. A variety of treatments, such as GcMAF, Hyper T/NK cells, Coley vaccine, gene therapy, cancer vaccines, and intravenous high-dose vitamin C or a-lipoic acid are routinely used to stimulate the immune system.
机译:Saisei Mirai总部位于日本大阪,是一家专门从事癌症免疫疗法的医疗组织。 Saisei Mirai这个名字源于日语单词,代表了再生和未来。我们的使命是为癌症患者提供最新,最有效的治疗方法,同时还要确保最佳的生活质量。癌症免疫疗法是利用免疫系统排斥癌症。特别是,它涉及刺激患者的免疫系统以定位和消除癌细胞。这是通过免疫细胞(例如自然杀伤细胞(NK细胞),T淋巴细胞,树突状细胞(DC)和巨噬细胞)实现的。通常使用各种疗法,例如GcMAF,Hyper T / NK细胞,Coley疫苗,基因疗法,癌症疫苗和静脉内大剂量维生素C或α-硫辛酸来刺激免疫系统。

著录项

  • 来源
    《Nature》 |2012年第7400期|p.A1-A5|共5页
  • 作者单位

    Department of Life System, Institute of Technology and Science, Graduate School, The University of Tokushima, 2-1 Minamijosanjima-cho, Tokushima, Japan;

    Department of Life System, Institute of Technology and Science, Graduate School, The University of Tokushima, 2-1 Minamijosanjima-cho, Tokushima, Japan;

    Saisei Mirai Cell Processing Center, Nature21 Building 3F, 3-34-8 Okubo-cho,Moriguchi, Osaka, Japan;

    Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan;

    Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan, Division of Food and Drug Evaluation Science, Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku,Kobe, Japan;

    Inui Immunotherapy Clinic, 6-14-17 Kindacho, Moriguchi, Osaka, Japan;

    Saisei Mirai Cell Processing Center, Nature21 Building 3F, 3-34-8 Okubo-cho,Moriguchi, Osaka, Japan, Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan, Inui Immunotherapy Clinic, 6-14-17 Kindacho, Moriguchi, Osaka, Japan;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号